Patent intelligence · CA
CA 2931112
IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE
IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE
Patent details — CA 2931112
- Jurisdiction
- CA
- Status
- granted
- Grant date
- May 28, 2015
- Expiration
- May 23, 2035
- Applicant
- LA JOLLA INST ALLERGY & IMMUNOLOGY [US]
- CPC classes
- A61K 39/ 02 A I, A61K 39/ 36 A I, A61K/3936
Quick answer
CA 2931112 (IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE) is held by LA JOLLA INST ALLERGY & IMMUNOLOGY [US]. Status: granted. Granted May 28, 2015. Expires May 23, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LA JOLLA INST ALLERGY & IMMUNOLOGY [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 02 A I, A61K 39/ 36 A I, A61K/3936
More from LA JOLLA INST ALLERGY & IMMUNOLOGY [US]
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted -
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
granted
Frequently asked questions
What is US patent 2931112?
CA 2931112 (IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE) is held by LA JOLLA INST ALLERGY & IMMUNOLOGY [US]. Status: granted. Granted May 28, 2015. Expires May 23, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2931112?
LA JOLLA INST ALLERGY & IMMUNOLOGY [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CA 2931112 expire?
Our index shows an expiration date of May 23, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.